U.S. Market Community

Microsoft is spending heavily to build out the computing power behind its AI push, and the market is treating that like a problem even though the core business stays strong. If that spending starts paying off, investors could get a rare chance to buy a high-quality tech giant when sentiment is unusually cautious.Read more

Veeva runs behind-the-scenes software that drugmakers rely on for tightly controlled work, where a mistake can slow a study or paperwork needed to bring medicines to patients. With new AI tools being built right into those existing systems, the big question is whether Veeva can turn that built-in trust into a new wave of growth—without investors overpaying.Read more

After a rocky early launch, Iovance now has a cancer treatment already cleared for use, and the story shifts from “will it work?” to “can it catch on” as more hospitals come on board and manufacturing improves. If results in other hard-to-treat cancers hold up, the company could grow far beyond melanoma—and it may even draw interest from a bigger drugmaker looking to fill future gaps.Read more

Fiserv is getting punished after leadership shake-ups, customer pushback, and missteps that shook confidence in its payment and banking tech businesses. The bull case is that new leaders can rebuild trust, keep key customers locked in, and use strong cash generation to shrink the share count if performance steadies.Read more

SpaceX’s debut could be the kind of headline deal that feels impossible to miss—yet the biggest risk may be buying into the excitement before the dust settles. The case here is that hype, limited early trading supply, and insider selling windows often give patient buyers a better shot later.Read more

PayPal looks like a fading payments app, but its core business may only need to stop slipping for sentiment to flip—especially while it keeps shrinking its share count and leaning on its huge user network. The big question is whether its everyday checkout and peer-to-peer use can hold up against cheaper bank transfers and a future where AI shopping tools choose the payment method for you.Read more

Meta keeps piling into big new bets like the metaverse and AI, and now it may even try to build a cloud business to make that spending pay off. The bigger question is whether these moves fit a clear long-term plan—or are costly pivots that could distract from what already works.Read more

FIGS sells stylish medical workwear, and the story here is that its brand is still gaining followers even as the economy slows spending. See why its direct-to-customer approach, new products, international expansion, and a team-bulk ordering push could lift the business—alongside the key risks if it fails to execute or demand weakens.Read more

Nike still looks like a strong brand with a loyal customer base, but growth has cooled and the business may need time to find its next stride. The key question is whether today’s price already assumes a smooth rebound, or whether patient buyers might get a better entry if the turnaround takes longer.Read more